Belpointe Asset Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,627	Closed	-$644K	–	946
2024 Q1	$644K	Buy	+1,627	New	+$602K	0.05%	378
2023 Q2	–	Sell	-1,862	Closed	-$645K	–	3393
2023 Q1	$645K	Buy	1,862 +1,584	+570%	+$463K	0.03%	460
2022 Q4	$65.5K	Buy	+278	New	+$65.9K	﹤0.01%	1465
2022 Q3	–	Sell	-1,504	Closed	-$454K	–	1241
2022 Q2	$454K	Buy	1,504 +355	+31%	+$116K	0.03%	528
2022 Q1	$472K	Buy	1,149 +894	+351%	+$350K	0.03%	556
2021 Q4	$119K	Buy	255 +13	+5%	+$5.6K	0.01%	1121
2021 Q3	$103K	Buy	+242	New	+$102K	0.01%	1153
2021 Q2	–	Sell	-2,464	Closed	-$694K	–	1187
2021 Q1	$694K	Buy	+2,464	New	+$705K	0.06%	329
2020 Q3	–	Sell	-2,295	Closed	-$522K	–	827
2020 Q2	$522K	Buy	+2,295	New	+$451K	0.07%	295